Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

V1512 – Treatment of Parkinson’s Disease

Drug (brand/generic)

V1521

Company/licensee

Vernalis

Therapy class

Levodopa

Product description

Dopamine precursor

Current indication

Parkinson’s disease

Market sector

CNS

Development status

Phase III
Expand
Close
Close
Close

Go Top